We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
AUM
$365M
AUM Growth
+$46.1M
Cap. Flow
+$37.6M
Cap. Flow %
10.3%
Top 10 Hldgs %
19.35%
Holding
1,326
New
84
Increased
304
Reduced
473
Closed
56

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
ORCL icon
Oracle
ORCL
+$1.05M
3
ETP
Energy Transfer Partners L.p.
ETP
+$657K
4
HDB icon
HDFC Bank
HDB
+$522K
5
BA icon
Boeing
BA
+$473K

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Healthcare 11.88%
3 Financials 10.98%
4 Consumer Discretionary 8.56%
5 Energy 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETY icon
301
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.27B
$217K 0.06%
19,275
+15,199
+373% +$172K
BG icon
302
Bunge Global
BG
$23.6B
$216K 0.06%
2,895
-57
-2% -$4.34K
BP icon
303
BP
BP
$113B
$212K 0.06%
6,902
+244
+4% +$7.59K
BABA icon
304
Alibaba
BABA
$269B
$211K 0.06%
1,500
MCHP icon
305
Microchip Technology
MCHP
$42.8B
$210K 0.06%
5,440
+5,000
+1,136% +$197K
CSII
306
DELISTED
Cardiovascular Systems, Inc.
CSII
$210K 0.06%
6,550
+1,150
+21% +$35K
GLAD icon
307
Gladstone Capital
GLAD
$425M
$209K 0.06%
10,650
+3,000
+39% +$58.7K
KSU
308
DELISTED
Kansas City Southern
KSU
$209K 0.06%
+2,435
New +$228K
SAN icon
309
Banco Santander
SAN
$194B
$208K 0.06%
32,513
+188
+0.6% +$1.17K
XPH icon
310
State Street SPDR S&P Pharmaceuticals ETF
XPH
$469M
$208K 0.06%
4,830
ARCC icon
311
Ares Capital
ARCC
$13.5B
$208K 0.06%
12,678
-1,666
-12% -$28.1K
WEC icon
312
WEC Energy
WEC
$37.7B
$206K 0.06%
3,358
THO icon
313
Thor Industries
THO
$3.99B
$206K 0.06%
1,967
+367
+23% +$35.5K
IVW icon
314
iShares S&P 500 Growth ETF
IVW
$72.5B
$204K 0.06%
5,992
+2,496
+71% +$84.6K
TY icon
315
TRI-Continental Corp
TY
$1.86B
$201K 0.06%
8,300
+1,774
+27% +$42.3K
PSK icon
316
State Street SPDR ICE Preferred Securities ETF
PSK
$693M
$200K 0.05%
4,445
+1,333
+43% +$59.8K
MIDD icon
317
Middleby
MIDD
$6.05B
$198K 0.05%
1,626
+1,460
+880% +$193K
AEIS icon
318
Advanced Energy
AEIS
$12.2B
$197K 0.05%
2,950
-1,000
-25% -$73.1K
NEE icon
319
NextEra Energy
NEE
$187B
$195K 0.05%
5,580
+596
+12% +$20.4K
RSPF icon
320
Invesco S&P 500 Equal Weight Financials ETF
RSPF
$304M
$195K 0.05%
4,957
+2,783
+128% +$106K
VOT icon
321
Vanguard Mid-Cap Growth ETF
VOT
$19B
$194K 0.05%
1,652
-202
-11% -$23.5K
EFOR
322
Everforth Inc
EFOR
$845M
$194K 0.05%
3,590
-200
-5% -$10.3K
WCC
323
WESCO International
WCC
$16.2B
$193K 0.05%
3,367
-1
-0% -$62
QTEC icon
324
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.4B
$193K 0.05%
3,090
+1,794
+138% +$112K
AET
325
DELISTED
Aetna Inc
AET
$191K 0.05%
1,260

Similar funds

Winslow Evans & Crocker's Q2 2017 Portfolio in Review

As of Q2 2017, Winslow Evans & Crocker held 1,326 positions worth $365M, up 14% from $318M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Winslow Evans & Crocker deployed $37.6M of net new capital in Q2 2017, opening 84 new positions and adding to 304 existing holdings. Its largest new stake was Idexx Laboratories: 3,900 shares worth $629K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Allergan plc, an estimated $3.44M trimmed.

  • Winslow Evans & Crocker's largest Q2 2017 buy was Idexx Laboratories: 3,900 shares worth $629K.
  • Winslow Evans & Crocker added most to Microsoft in Q2 2017, an estimated $3.28M increase.
  • Winslow Evans & Crocker's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $3.44M.
  • Winslow Evans & Crocker fully exited State Street Energy Select Sector SPDR ETF in Q2 2017, selling an estimated $428K.
  • Winslow Evans & Crocker's ten largest holdings make up 19% of its $365M portfolio in Q2 2017.
  • Winslow Evans & Crocker opened 84 new positions and closed 56 in Q2 2017.
  • Winslow Evans & Crocker's portfolio value rose 14% quarter-over-quarter to $365M.

Based on Winslow Evans & Crocker's 13F filing for Q2 2017, filed 14 Jul 2017.